Beyond The Printed Page

  1. What Makes A Biopharma Serial Entrepreneur Tick? Part 1

    Rob Wright explores what makes a serial entrepreneur tick (part 1) via Brad Margus, cofounder and CEO of Cerevance. Margus may have started out in the shrimping business, but he went on to found a disease specific 501c3 nonprofit, ultimately leading him to found three different biopharmaceutical companies.

  2. What Makes A Biopharma Serial Entrepreneur Like Brad Margus Tick? Part 2

    In part 2 of what makes serial entrepreneur Brad Margus tick, Rob Wright explores the various lessons learned by Margus during the founding of multiple biopharmaceutical companies, along with an update on the 501c3 nonprofit organization he helped to cofound, the A-T Children’s Project.

  3. The Effect Of Having A Rock Star Cofounder

    John Oyler, cofounder and CEO of BeiGene, a 9-year-old global biopharmaceutical company today valued at more than $8.5 billion, discusses the importance of having a “rock star” scientist cofounder in Xiandong Wang, Ph.D., and his impact on recruiting top talent.

  4. Thinking About Becoming An Impact Investor?

    Catherine Clark, a professor at Duke University specializing in impact investing, provides six pieces of wisdom for those considering becoming impact investors.

  5. The Lonely Role Of CEO

    Matt Patterson, chairman and CEO of Audentes Therapeutics, provides perspective on what it’s like being the CEO of a startup biopharmaceutical company. Spoiler alert, it isn’t all glitz and glam.

  6. What Prepared Matt Patterson To Be CEO Of Audentes Therapeutics

    Matt Patterson, chairman and CEO of Audentes Therapeutics, discusses the experiences that best prepared him for being the CEO of a biopharmaceutical company, including brushes with industry icon Henri Termeer.

  7. Pfizer’s Head Of R&D On The Importance Of Being Hyper Focused

    Pfizer’s top scientist, Mikael Dolsten, M.D., Ph.D., talks about being hyper focused during company’s R&D turnaround amongst CEO turnover, company integrations and M&A.

  8. How Tony Robbins Became An Investor In Celularity

    Robert Hariri, M.D., Ph.D., discusses how he became friends with life coach Tony Robbins, and why Robbins decided to invest in his company.

  9. Support For Women-Led Early-Stage Life Sciences Companies

    A preview of an October 2109 issue article that discusses the results of the 2018 MassNextGen initiative that provides funding and coaching support to early-stage life sciences companies started by females.

  10. Robert Hariri’s Accidental Entry Into Filmmaking

    Robert Hariri, M.D., Ph.D., CEO of Celularity Therapeutics, shares how a biopharmaceutical industry CEO has come to know Hollywood celebrities.